H.R. 5880

119th Congress

In Committee

Fight Illicit Pill Presses Act

Sponsored byRepublican:Rep. Hageman, Harriet M. [R-WY-At Large]WY· Introduced 31 October 2025

14

Cosponsors

7

Actions

0

Amendments

2

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Forwarded by Subcommittee to Full Committee by Voice Vote.

15 July 2026·1 week ago

Summary

Introduced in House · Updated 7 July 2026

Fight Illicit Pill Presses Act

This bill broadens the scope of pill machines that are subject to regulation under the Controlled Substances Act (CSA). The bill also requires regulated machines to have serial numbers and imposes criminal penalties for conduct involving the removal of serial numbers or the transportation of regulated machines knowing the serial numbers have been removed.

Currently, the CSA requires persons who manufacture, distribute, import, export, or purchase certain regulated machines to keep records of and report on transactions involving the machines. Currently, the term regulated machines includes tableting machines and encapsulating machines.

This bill requires persons who sell or deliver regulated machines to comply with the CSA's recordkeeping and reporting requirements, in addition to persons who manufacture, distribute, import, export, or purchase them.

The bill also expands regulated machines, for which transactions must be recorded and reported, to include critical parts of tableting and encapsulating machines such as dies used to mold pills and punches used to imprint markings and logos onto pills.

The bill requires serial numbers to be permanently affixed to encapsulating machines, tableting machines, and critical parts of tableting and encapsulating machines.

Finally, the bill prohibits, subject to criminal penalties, the (1) removal, alteration, or obliteration of any serial number affixed to a tableting machine, encapsulating machine, or a critical part; or (2) transportation, shipment, receipt, possession, distribution, delivery, sale, import, or export of any tableting machine, encapsulating machine, or critical part knowing the serial number has been removed, altered, or obliterated.

Timeline

7 actions

  1. Subcommittee Consideration and Mark-up Session Held

    15 July 2026 · Committee

  2. Forwarded by Subcommittee to Full Committee by Voice Vote.

    15 July 2026 · Committee

  3. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    31 October 2025 · IntroReferral

  4. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    31 October 2025 · IntroReferral

  5. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    31 October 2025 · IntroReferral

  6. Introduced in House

    31 October 2025 · IntroReferral

  7. Introduced in House

    31 October 2025 · IntroReferral

  8. Introduced in House

    31 October 2025 · IntroReferral

  9. Introduced in House

    31 October 2025 · IntroReferral

Sponsorship

14 cosponsors

Cosponsors

  • Democrat1071%
  • Republican429%

Classification

Policy area

Crime and Law Enforcement

Committees

2

  • Energy and Commerce Committee

    House · Standing

    • Referred To31 Oct 2025
  • Judiciary Committee

    House · Standing

    • Referred To31 Oct 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 4 on 31 October 2025 to 14 on 23 February 2026.

Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.